These stocks are likely to be in focus on February 3
Last Updated: 2nd February 2022 - 05:32 pm
At market close on Wednesday, the core equity indices, Sensex and Nifty ended up more than 1% on the upside. The Sensex was at 59,558.33, up by 695.76 points or 1.18% and the Nifty was at 17,780, up by 203.15 points or 1.16%.
These stocks are likely to be in focus for Wednesday's trading session –
Alembic Pharma Limited: Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Toviaz Extended-Release Tablets, 4 mg and 8 mg, of Pfizer Inc. Fesoterodine Fumarate Extended-Release Tablets, are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg have an estimated market size of US$ 225 million for twelve months ending September 2021, according to IQVIA. The company’s stock was at Rs 772.30, up by 1.33% on the BSE.
Jubilant FoodWorks Limited: Jubilant FoodWorks reported a growth of 9.8% in net profit to Rs 1,373 crore as revenue from operations rose by 12.9% to Rs 11,935 crore in Q3 FY22 over Q3 FY21. EBITDA in Q3 FY22 was Rs 3,174 crore, up by 13.9% from Rs 2,786 crore in Q3 FY21. EBITDA margin was 26.6% in Q3 FY22 against 26.4% in Q3 FY21. The quarter also saw record new store openings with a landmark 75 new Domino's stores being opened. The company forayed into 17 new cities during the quarter, it now reaches a total of 322 cities across India. The scrip was down by 4.04% at Rs 3301.25, at market close.
Housing Development Finance Corporation Limited: HDFC Ltd reported a profit after tax of Rs 3,261 crore in Q3FY22 compared to Rs 2,926 crore in the corresponding quarter of the previous year, posting a growth of 11% Y-o-Y. The total revenue from operations of the company came at Rs 11783 crore in the October-December quarter as against Rs 11707 crore in a year-ago quarter, up by 0.60% Y-o-Y. The gross non-performing assets came at 2.32% from 2 quarter-on-quarter. The stock of the lending company was up by 1.87% at Rs 2612 per share on BSE.
52-week high stocks – From the BSE 200 pack, the stocks of Canara Bank, AU Small Finance Bank, Bank of Baroda, and Sun Pharmaceuticals also have hit their 52-week high on Wednesday.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advance Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.